WO2019129809A1 - Matériau bionanohybride, son procédé de préparation et son utilisation - Google Patents
Matériau bionanohybride, son procédé de préparation et son utilisation Download PDFInfo
- Publication number
- WO2019129809A1 WO2019129809A1 PCT/EP2018/097026 EP2018097026W WO2019129809A1 WO 2019129809 A1 WO2019129809 A1 WO 2019129809A1 EP 2018097026 W EP2018097026 W EP 2018097026W WO 2019129809 A1 WO2019129809 A1 WO 2019129809A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- bionanohybrid
- nanowires
- enzyme
- iron
- process according
- Prior art date
Links
- 239000000463 material Substances 0.000 title claims description 65
- 238000004519 manufacturing process Methods 0.000 title claims description 7
- 239000002070 nanowire Substances 0.000 claims abstract description 63
- 229910000015 iron(II) carbonate Inorganic materials 0.000 claims abstract description 44
- 102000004190 Enzymes Human genes 0.000 claims abstract description 30
- 108090000790 Enzymes Proteins 0.000 claims abstract description 30
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 20
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 20
- 239000012279 sodium borohydride Substances 0.000 claims abstract description 16
- 229910000033 sodium borohydride Inorganic materials 0.000 claims abstract description 16
- 230000015556 catabolic process Effects 0.000 claims abstract description 14
- 238000006731 degradation reaction Methods 0.000 claims abstract description 14
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical class [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 claims abstract description 8
- PLIKAWJENQZMHA-UHFFFAOYSA-N 4-aminophenol Chemical compound NC1=CC=C(O)C=C1 PLIKAWJENQZMHA-UHFFFAOYSA-N 0.000 claims description 42
- 238000000034 method Methods 0.000 claims description 26
- 230000008569 process Effects 0.000 claims description 25
- BTJIUGUIPKRLHP-UHFFFAOYSA-N 4-nitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1 BTJIUGUIPKRLHP-UHFFFAOYSA-N 0.000 claims description 24
- 239000003054 catalyst Substances 0.000 claims description 17
- 239000000243 solution Substances 0.000 claims description 17
- 239000011159 matrix material Substances 0.000 claims description 16
- 238000006243 chemical reaction Methods 0.000 claims description 15
- 239000000203 mixture Substances 0.000 claims description 15
- 230000009467 reduction Effects 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 12
- 239000007864 aqueous solution Substances 0.000 claims description 12
- 238000003756 stirring Methods 0.000 claims description 11
- 238000011534 incubation Methods 0.000 claims description 9
- 102000004882 Lipase Human genes 0.000 claims description 6
- 108090001060 Lipase Proteins 0.000 claims description 6
- 239000004367 Lipase Substances 0.000 claims description 6
- 235000019421 lipase Nutrition 0.000 claims description 6
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 6
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 6
- 241001661345 Moesziomyces antarcticus Species 0.000 claims description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims description 2
- 230000015572 biosynthetic process Effects 0.000 abstract description 16
- 238000003786 synthesis reaction Methods 0.000 abstract description 13
- 230000003197 catalytic effect Effects 0.000 abstract description 12
- 230000003647 oxidation Effects 0.000 abstract description 5
- 238000007254 oxidation reaction Methods 0.000 abstract description 5
- 239000002957 persistent organic pollutant Substances 0.000 abstract description 4
- 239000004277 Ferrous carbonate Substances 0.000 abstract description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 abstract 1
- 239000003638 chemical reducing agent Substances 0.000 abstract 1
- 238000010952 in-situ formation Methods 0.000 abstract 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 49
- 229910052742 iron Inorganic materials 0.000 description 18
- 238000006722 reduction reaction Methods 0.000 description 14
- 238000002441 X-ray diffraction Methods 0.000 description 13
- 230000005291 magnetic effect Effects 0.000 description 12
- 238000004458 analytical method Methods 0.000 description 11
- 239000002086 nanomaterial Substances 0.000 description 11
- 239000002105 nanoparticle Substances 0.000 description 10
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 9
- 238000001228 spectrum Methods 0.000 description 9
- 238000004627 transmission electron microscopy Methods 0.000 description 8
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 7
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 7
- 229910052751 metal Inorganic materials 0.000 description 7
- 239000002184 metal Substances 0.000 description 7
- 238000004128 high performance liquid chromatography Methods 0.000 description 6
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 241000894007 species Species 0.000 description 6
- 238000004833 X-ray photoelectron spectroscopy Methods 0.000 description 5
- RAQDACVRFCEPDA-UHFFFAOYSA-L ferrous carbonate Chemical compound [Fe+2].[O-]C([O-])=O RAQDACVRFCEPDA-UHFFFAOYSA-L 0.000 description 5
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 238000006555 catalytic reaction Methods 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000002354 inductively-coupled plasma atomic emission spectroscopy Methods 0.000 description 4
- 235000013980 iron oxide Nutrition 0.000 description 4
- 239000008188 pellet Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 3
- 239000012736 aqueous medium Substances 0.000 description 3
- 238000012512 characterization method Methods 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 239000010414 supernatant solution Substances 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 2
- 239000000356 contaminant Substances 0.000 description 2
- 239000011258 core-shell material Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 235000019268 ferrous carbonate Nutrition 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000011019 hematite Substances 0.000 description 2
- 229910052595 hematite Inorganic materials 0.000 description 2
- 238000002173 high-resolution transmission electron microscopy Methods 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- LIKBJVNGSGBSGK-UHFFFAOYSA-N iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[Fe+3].[Fe+3] LIKBJVNGSGBSGK-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000002122 magnetic nanoparticle Substances 0.000 description 2
- 230000005389 magnetism Effects 0.000 description 2
- 229940031182 nanoparticles iron oxide Drugs 0.000 description 2
- -1 needles Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 229960005489 paracetamol Drugs 0.000 description 2
- 230000005298 paramagnetic effect Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 229910021646 siderite Inorganic materials 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- GNENVASJJIUNER-UHFFFAOYSA-N 2,4,6-tricyclohexyloxy-1,3,5,2,4,6-trioxatriborinane Chemical compound C1CCCCC1OB1OB(OC2CCCCC2)OB(OC2CCCCC2)O1 GNENVASJJIUNER-UHFFFAOYSA-N 0.000 description 1
- WXNZTHHGJRFXKQ-UHFFFAOYSA-N 4-chlorophenol Chemical compound OC1=CC=C(Cl)C=C1 WXNZTHHGJRFXKQ-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 101100273064 Brassica oleracea var. botrytis CAL-B gene Proteins 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 229910002483 Cu Ka Inorganic materials 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 229910002588 FeOOH Inorganic materials 0.000 description 1
- 241000976924 Inca Species 0.000 description 1
- 208000022120 Jeavons syndrome Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 206010029155 Nephropathy toxic Diseases 0.000 description 1
- 238000003917 TEM image Methods 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000000035 biogenic effect Effects 0.000 description 1
- JZUAITAPPPWUSR-UHFFFAOYSA-N bis(selanylidene)iron Chemical compound [Fe](=[Se])=[Se] JZUAITAPPPWUSR-UHFFFAOYSA-N 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 230000004611 cancer cell death Effects 0.000 description 1
- 230000006652 catabolic pathway Effects 0.000 description 1
- 238000010531 catalytic reduction reaction Methods 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- AXCXNCAUYZRGHF-UHFFFAOYSA-N dibutoxy(phenyl)borane Chemical compound CCCCOB(OCCCC)C1=CC=CC=C1 AXCXNCAUYZRGHF-UHFFFAOYSA-N 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000005868 electrolysis reaction Methods 0.000 description 1
- 238000001523 electrospinning Methods 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- IMBKASBLAKCLEM-UHFFFAOYSA-L ferrous ammonium sulfate (anhydrous) Chemical compound [NH4+].[NH4+].[Fe+2].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O IMBKASBLAKCLEM-UHFFFAOYSA-L 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000003673 groundwater Substances 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 150000002505 iron Chemical class 0.000 description 1
- 235000014413 iron hydroxide Nutrition 0.000 description 1
- VBMVTYDPPZVILR-UHFFFAOYSA-N iron(2+);oxygen(2-) Chemical class [O-2].[Fe+2] VBMVTYDPPZVILR-UHFFFAOYSA-N 0.000 description 1
- NCNCGGDMXMBVIA-UHFFFAOYSA-L iron(ii) hydroxide Chemical compound [OH-].[OH-].[Fe+2] NCNCGGDMXMBVIA-UHFFFAOYSA-L 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 239000000696 magnetic material Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 239000011943 nanocatalyst Substances 0.000 description 1
- 239000002064 nanoplatelet Substances 0.000 description 1
- 239000002073 nanorod Substances 0.000 description 1
- 239000002077 nanosphere Substances 0.000 description 1
- 239000008239 natural water Substances 0.000 description 1
- 230000007694 nephrotoxicity Effects 0.000 description 1
- 231100000417 nephrotoxicity Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 239000010970 precious metal Substances 0.000 description 1
- 239000012460 protein solution Substances 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000003642 reactive oxygen metabolite Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000004626 scanning electron microscopy Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 239000002352 surface water Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 230000003390 teratogenic effect Effects 0.000 description 1
- 238000000825 ultraviolet detection Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
- B01J23/70—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of the iron group metals or copper
- B01J23/74—Iron group metals
- B01J23/745—Iron
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J27/00—Catalysts comprising the elements or compounds of halogens, sulfur, selenium, tellurium, phosphorus or nitrogen; Catalysts comprising carbon compounds
- B01J27/20—Carbon compounds
- B01J27/232—Carbonates
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J35/00—Catalysts, in general, characterised by their form or physical properties
- B01J35/20—Catalysts, in general, characterised by their form or physical properties characterised by their non-solid state
- B01J35/23—Catalysts, in general, characterised by their form or physical properties characterised by their non-solid state in a colloidal state
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J35/00—Catalysts, in general, characterised by their form or physical properties
- B01J35/30—Catalysts, in general, characterised by their form or physical properties characterised by their physical properties
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J35/00—Catalysts, in general, characterised by their form or physical properties
- B01J35/40—Catalysts, in general, characterised by their form or physical properties characterised by dimensions, e.g. grain size
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J35/00—Catalysts, in general, characterised by their form or physical properties
- B01J35/50—Catalysts, in general, characterised by their form or physical properties characterised by their shape or configuration
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
- C01G49/00—Compounds of iron
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2002/00—Crystal-structural characteristics
- C01P2002/70—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data
- C01P2002/72—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data by d-values or two theta-values, e.g. as X-ray diagram
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2002/00—Crystal-structural characteristics
- C01P2002/80—Crystal-structural characteristics defined by measured data other than those specified in group C01P2002/70
- C01P2002/85—Crystal-structural characteristics defined by measured data other than those specified in group C01P2002/70 by XPS, EDX or EDAX data
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2004/00—Particle morphology
- C01P2004/01—Particle morphology depicted by an image
- C01P2004/04—Particle morphology depicted by an image obtained by TEM, STEM, STM or AFM
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2004/00—Particle morphology
- C01P2004/10—Particle morphology extending in one dimension, e.g. needle-like
- C01P2004/16—Nanowires or nanorods, i.e. solid nanofibres with two nearly equal dimensions between 1-100 nanometer
Definitions
- the invention relates to a high stable heterogeneous bionanohybrid material comprising protein and iron (II) carbonate nanowires (FeC03-NWs), process for the synthesis thereof and its use as a catalyst.
- a high stable heterogeneous bionanohybrid material comprising protein and iron (II) carbonate nanowires (FeC03-NWs), process for the synthesis thereof and its use as a catalyst.
- Iron is the most abundant metal in the planet, so being relative inexpensive, relatively nontoxic (considered by the regulatory authorities a “metal with minimum safety concern)(Medicines Agency, Guideline on the Specification Limits for Residues of Metal Catalysts or Metal Reagents, EMEA/ CHMP/SWP/4446/2000, London, February 21 , 2008) in comparison with other precious metals.
- iron (Fe) is one of the mostly used metals for industrial applications.
- Iron catalysis has gained an extraordinary attention in organic synthesis in the last years (Bauer, I., Knolker, H.J. Iron Catalysis in Organic Synthesis. Chem. Rev., 2015, 115, 3170) and the design and development of new kind of iron catalysts is highly desirable.
- iron nanostructures have been strongly developed in the last years with different interesting properties (Nor, Y.A., Zhou, L., Meka, A.K., Xu, C., Niu, Y., Zhang, H., Mitter, N., Mahony, D., Yu, C. Engineering Iron Oxide Hollow Nanospheres to Enhance Antimicrobial Property: Understanding the Cytotoxic Origin in Organic Rich Environment. Adv. Func. Mat. 2016, 26, 5408; Gao, R., Zhang, H., Yan, D. Iron diselenide nanoplatelets: Stable and efficient water- electrolysis catalysts, Nano Energy, 2017 ,31, 90).
- Magnetite (Fe304) nanoparticles are by far the most studied phase, and are applied in different areas, mainly with biomedical purpose (Arami, H., Khandhar, A., Liggitt, D., Krishnan, K. M. In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles. Chem. Soc. Rev. 2015,44, 8576).
- iron nanostructures where depending on the metal source and experimental conditions the corresponding iron species and nanostructure is obtained.
- the most typical iron species which can be obtained as nanoparticles are iron oxides hematite (a-Fe203), maghemite (y-Fe203), magnetite (Fe304), iron hydroxide (FeOOH) and in particular cases, a-Fe.
- This last iron specie is quite difficult to obtain because of the extremely sensitivity of iron to oxidation under air conditions, exhibiting a core-oxide shell structure inevitably.
- Fe and Fe oxides has been described to be synthesized mainly as nanoparticles with an average size from 10 to 100 mn.
- Some process about the use of biomolecules (e.g. bacteria or plants) to synthesize of these nanoparticles has been described although in most of cases high size nanoparticles are obtained (Rufus, A., Sreeju, N., Philip, D. Synthesis of biogenic hematite (a-Fe203) nanoparticles for antibacterial and nanofluid applications. RSC Advances, 2016, 6, 94206).
- magnetic nanowires offer potential advantages over magnetic nanoparticles because of their larger surface area to volume ratio and higher magnetic moments originated from their strong shape anisotropy.
- Fe NWs has been successfully applied for example in comparison with other metal NWs with lower impact on cell viability (Martinez-Banderas, A.I., Aires, A., Teran, F.J., Perez, J.E., Cadenas, J.F., Alsharif, N., Ravasi, T., Cortajarena, A.L., Kosel, J. Functionalized magnetic nanowires for chemical and magneto-mechanical induction of cancer cell death, Scientific Reports, 2016, vol. 6).
- Fe NWs, Fe203 or combination Fe/Fe203 or Fe/Fe304 nanowires were synthesized with an average diameter of 30 to 100 nm and length of 800 nm to 1 -2 pm as the best results in literature(Lupan, O., Postica, V., Wolff, N., Polonskyi, O., Duppel, V., Kaidas, V., Lazari, E., Ababii, N., Faupel, F., Kienle, L, Adelung, R.
- Fe Nanowires has been used in catalytic process, for example in the degradation of organic molecules (Huang, Q., Cao, M., Ai, Z., Zhang, L. Reactive oxygen species dependent degradation pathway of 4-chlorophenol with Fe@Fe 2 0 3 core-shell nanowires. Applied Catalysis B: Environ, 2015 , 162, 319) or oxygen evolution reaction (OER) in U-0 2 batteries (Wang, F., Wu, X., Shen, C., Wen, Z. Facile synthesis of Fe@Fe203 core-shell nanowires as O2 electrode for high-energy U-O2 batteries, J. Solid State Electrochem., 2016, 20, 1831 ).
- the present invention provides a new process to produce of protein-FeC03 nanowires bionanohybrid materials showing magnetic properties.
- the bionanohybrids are efficient catalysts in the degradation of organic compounds.
- the present invention discloses a protein-iron carbonate nanowires bionanohybrid material and the process for preparing thereof in aqueous media and in soft conditions.
- the iron carbonate nanowires (FeC03 NWs) in the bionanohybrid material have an average diameter between 5 and 7 nm and average length of between 40 and 93 nm, showing magnetic properties and high catalytic capacity in the degradation of organic pollutants.
- a first aspect of the present invention relates to a bionanohybrid material comprising:
- FeC03 nanowires are embedded in the matrix.
- the FeC03 nanowires are homogeneously distributed within the matrix.
- the matrix is formed by the enzyme Candida antarctica lipase.
- the FeC03 nanowires have an average length between 40 nm and 93 nm, and/or have an average diameter between 5 nm and 7 nm.
- the FeC03 nanowires have an average diameter of 5 nm.
- the FeC03 nanowires have an average diameter of 5 nm and an average length of 40 nm.
- the FeC03 nanowires have an average length of 59 nm and/or an average diameter of 7 nm.
- the bionanohybrid material having an average diameter of 5 nm is paramagnetic.
- the interactions between the matrix and the FeC03 nanowires are non- covalent.
- the bionanohybrid material has 47% by weight in Fe, obtained by elemental analysis ICP-OES (inductively coupled plasma optical emission spectrometry).
- a second aspect of the present invention relates to a process for preparing protein-FeC03 nanowires bionanohybrid material.
- the process comprises the next steps: a) addition under stirring of a protein or enzyme and of an iron (II) salt to an aqueous solution of sodium bicarbonate, wherein the pH of the aqueous solution of sodium bicarbonate is between the isoelectric point of the enzyme and 10, not including the isoelectric point of the enzyme, and wherein the isoelectric point of the protein or enzyme is below 10, b) incubation of the mixture obtained in step a) for a time between 14-16 h to obtain a bionanohybrid material (non-reduced bionanohybrid material).
- Incubation means that the mixture is left under stirring for the specified time.
- the bionanohybrid material obtained in step b) (also called in the present invention“non-reduced bionanohybrid material”), which is obtained in solid form in the suspension/mixture, is collected, washed with water and dried.
- This bionanohybrid material comprises a matrix comprising an enzyme or protein and FeC03 nanowires embedded in the matrix, wherein the FeC03 nanowires have an average length of 59 nm and an average diameter of 7 nm.
- the protein or enzyme induces the formation of nanowires.
- the protein or enzyme allows the homogeneous distribution of the nanowires and avoids the formation of aggregates.
- the process includes a step c) comprising the addition of sodium borohydride (reduction step) to the mixture obtained in step b) to form a bionanohybrid material (also called in the present invention “reduced bionanohybrid material”) in solid form, including smaller nanowires than the bionanohybrid material obtained in b), and collection of the solid formed in step c), washing with water and drying thereof.
- a step c) comprising the addition of sodium borohydride (reduction step) to the mixture obtained in step b) to form a bionanohybrid material (also called in the present invention “reduced bionanohybrid material”) in solid form, including smaller nanowires than the bionanohybrid material obtained in b), and collection of the solid formed in step c), washing with water and drying thereof.
- the combination of using a protein or enzyme for inducing the nanostructure formation and the use of sodium bicarbonate allows to synthesize for the first time iron (II) carbonate (siderite) nanowires.
- the reducing step (addition of sodium borohydride) permits to achieve FeC03 NWs smaller than those obtained in step b) and showing magnetic properties.
- the bionanohybrid material obtained in step c) comprises a matrix comprising an enzyme or protein and FeC03 nanowires embedded in the matrix, wherein the FeC03 nanowires have an average length between 40 nm and 93 nm and an average of 5 nm. More preferably, the bionanohybrid material obtained in step c) comprises FeC03 nanowires having an average diameter of 5 nm and an average length of 40 nm.
- the bionanohybrid material obtained in step c) presents paramagnetic properties.
- the pH of the aqueous solution of sodium bicarbonate in step a) must be above the isoelectric point of the enzyme and up to 10. Above pH 10, the synthesis of iron oxide nanoparticles is favored. The isoelectric point of the enzyme cannot be above 10.
- the bionanohybrid material obtained in step b) or c) is collected, washed with water and dried.
- the solution in step a) is stirring for avoiding iron oxidation.
- the stirring is carried out at between 340-380 rpm, more preferably at 380 rpm.
- the stirring speed is inferior to the above-mentioned range, the bionanohybrid material which is formed in solid form, would be deposited on the bottom so the bionanohybrid material would not be well-synthetized. On the contrary, if the stirring speed is higher than the above-mentioned range, oxidated side product would be formed.
- step a) in step a) is added the enzyme Candida antarctica lipase.
- the amount of enzyme or protein added in step a) is between 2.5 mg and 5 mg of enzyme or protein per 10 mL of the aqueous solution.
- step a) is carried out at room temperature (20- 25 Q C) and under air.
- step a) the addition of enzyme or protein is carried out at pH 10.
- iron salt concentration ranges from 5 to 100 mg/ml in the aqueous solution; more preferably, 10 mg/ml.
- the iron (II) salt is the sulfate of iron (II) and ammonium: (NH 4 ) 2 Fe(S04)2.
- the time of the incubation (step b)) is 16 h.
- step c) sodium borohydride is added to a final concentration of at least 0.12 M in the mixture, more preferably, between 0.12- 0.15 M.
- step c) the mixture of reaction is preferably allowed to react between 15 and 360 min, more preferably 30 min and even more preferably 15 min.
- the bionanohybrid material obtained in step b) or c) that has been collected, washed with water and dried is lyophilized.
- it is lyophilized for a time between 16 and 18 h., more preferably 16 h.
- the present invention also relates to a bionanohybrid material obtained by the process (in step b) or in step c)) described in the second aspect of the invention.
- the bionanohybrid material obtained by the process of the invention has the features of the bionanohybrid material described in the first aspect of the present invention.
- Another aspect of the present invention refers to the use of the bionanohybrid materials described in the present invention as catalysts.
- bionanohybrid materials described in the present invention are used as catalysts for degrading organic pollutants, preferably phenolic compounds.
- bionanohybrid materials both the reduced and the non- reduced bionanohybrid material
- pAP 4-aminophenol
- the reduced bionanohybrid material of the present invention is used for the reduction of 4-nitrophenol (pNP) to 4-aminophenol (pAP).
- pNP contamination of surface and ground-water has gradually increased due to the excessive consumption of dyes, pesticides, and pharmaceuticals from industrial and agricultural activities.
- United States Environmental Protection Agency set a guideline restricting the contaminant level of p-NP bellowing 10 ng/L in natural water.
- pAP is the hydrolytic product of acetaminophen (paracetamol) and it has been reported to have significant nephrotoxicity and teratogenic effects.
- nanowire in the present invention refers to an elongated nanostructure formed in a wire shape wherein the average length is between 40 to 93 nm and the average diameter is between 5 to 7 nm.
- an aspect ratio (diameter: length) of the nanowires of the present invention ranges from.5:40 to 7:93.
- bionanohybrid material in the present invention refers to a material comprising a protein or enzyme and wires with nanometric scale (“nanowires” as defined above).
- embedded in the present invention when referring to the FeC03 nanowires means that FeC03 nanowires are disposed within the matrix, so they are surrounded by the matrix material.
- this invention provides a simple and green technology to produce for the first time highly active, stable and reusable novel nanocatalysts; bionanohybrids constitute of very small iron carbonate nanowires in situ synthesized in a protein or enzyme matrix. These nanohybrids (nanohybrid material) present also magnetic properties, which permit a rapid recovering of the catalyst.
- FIG. 1 X-ray diffraction (XDR) spectrum of the bionanohybrid material obtained in example 2 of the present invention.
- FIG. 2 Transmission electron microscopy (TEM) images of FeC03 nanowires of bionanohybrid material obtained in example 2 of the present invention.
- TEM Transmission electron microscopy
- FIG. 3 Chemical scheme of the transformation of p-nitrophenol (pNP) into p- aminophenol (pAP).
- FIG. 4 X-ray diffraction (XDR) spectrum of the bionanohybrid material CAL-B- FeC03NWs-15 obtained in example 2 of the present invention.
- FIG. 5 TEM picture of the bionanohybrid material CAL-B-FeC03NWs-15 obtained in example 1 of the present invention.
- FIG. 6 X-ray photoelectron spectroscopy (XPS) spectra of (a) Fe2p and (b) 01 s for iron carbonate in CAL-B-FeC03NWs-15 bionanohybrid obtained in example 1 of the present invention.
- XPS X-ray photoelectron spectroscopy
- FIG. 7 Reduction of pNP catalyzed by of the bionanohybrid CAL-B- FeCOsNWs-15 in aqueous media after 20 sg of reaction.
- FIG. 8 Reduction of pNP catalyzed by others bionanohybrid (CAL-B- FeCO 3 NWs-30, CAL-B-FeC0 3 NWs-45, CAL-B-FeCO 3 NWs-60, CAL-B- FeCO 3 NWs-360) in aqueous media.
- FIG. 9 Comparison of the XDR spectrum of CAL-B-FeC0 3 NWs bionanohybrid obtained in example 2 of the present invention from the preparation (day 1 ) to 30 days after.
- FIG. 10 Comparison of the XDR spectrum of the bionanohybrid CAL-B- FeC03NWs-15 from the preparation (day 1 ) to 30 days after.
- FIG. 11 TEM analysis of the bionanohybrids after 30 days’ store.
- A) bionanohybrid material not treated with NaBH 4 (CAL-B-FeCOsNWs).
- B) bionanohybrid material treated with NaBH 4 for 15 min (CAL-B-FeC03NWs-15).
- Candida antartica B lipase (CAL-B) solution was from Novozymes (Denmark) (the concentration of the enzyme in the commercial solution is 5 mg /ml).
- Ammonium iron (II) sulfate hexahydrate [(NH 4 )2Fe(S04)2 x 6H2O (Mohr ' s salt)], hydrogen peroxide (33%), sodium bicarbonate and sodium borohydride were purchased by Sigma-Aldrich.
- Acetonitrile HPLC grade was purchased by Scharlab.
- ICP-AES Inductively coupled plasma atomic emission spectrometry
- XRD X-Ray diffraction
- XPS X-ray photoelectron analysis
- the reducing step with sodium borohydride was carried out for 15, 30, 60, 90 and 360 minutes to obtain the bionanohybrid materials: CAL-B-FeC03NWs-15, CAL-B-FeCO3NWs-30, CAL-B- FeCO3NWs-60, CAL-B-FeCOsNWs-90, CAL-B-FeCOsNWs-360, respectively.
- the obtained mixture was centrifuged at 8000 rpm for 5 min, (11 ml_ per falcon type tube). The generated pellet was re-suspended in 15 mL of water. The pH of the supernatant solution was measured to be approximately 9.
- Example 2 Synthesis bionanohvbrid material of the present invention without including the reduction step
- Example 3 Catalytic Reduction of 4-nitrophenol (pNP) to 4-aminophenol (pAP) by the bionanohvbrid materials of the present invention
- the fig. 3 shows the chemical scheme of the transformation of p-nitrophenol (pNP) into p-aminophenol (pAP).
- This bionanohybrid material (CAL-B-FeC03NWs-15) showed the higher catalytic capacity to complete convert p-NP to p-AP within 20 seconds (3 mg catalyst, 2 ml, 1 mM pNP) ( Figure 7).
- the CAL-B-FeCOsNWs-15 bionanohybrid was reused six cycles in the reduction of pNP using the conditions described above.
- the catalyst was washed with water once and centrifuged before the next reaction.
- the fresh catalyst was reused at least 6 reaction cycles in the reduction of pNP and more than 95% activity was conserved after that.
- Example 6 Catalytic Degradation of p-aminophenol (pAP) by bionanohvbrid materials of the present invention
- HPLC conditions were: an isocratic mixture of 30% acetonitrile and 70% bi-distilled water, UV detection at 275 nm and 225 nm using a Diode array detector, and a flow rate of 0.5 mL/min. Under these conditions, the retention times of pAP was 4.65 min, and for H2O2 was 3.3 min.
- the reaction was quantitatively followed by HPLC.
- the CAL-B-FeC03NWs-15 (obtained in example 1 ) and CAL-B-FeC03NWs (obtained in example 2) showed similar performance at these conditions and more than 98% degradation of pAP was achieved in 2 min (Table 2). No traces of any compounds were detected by HPLC after 50 min.
- Example 7 Stability of the bionanohvbrid materials of the present invention
- One important point for a possible industrial application of this protein-FeNWs bionanohybrids is the stability against oxidation.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Materials Engineering (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Catalysts (AREA)
Abstract
La présente invention concerne la synthèse de bionanohybrides de nanofils fortement stables hétérogènes de protéine-carbonate de fer (II) (FeCO3-NW). Ils ont été préparés au moyen d'une enzyme dans une solution de bicarbonate aqueuse et de sel de fer (II) à la température ambiante et à l'air. L'enzyme induisait la formation in situ des NW de FeCO3 sur le réseau de protéines. L'addition de NaBH4 comme agent de réduction a permis d'obtenir des NW de FeCO3 ayant un diamètre d'environ 5 nm et une longueur d'environ 40 nm. Ces nouveaux bionanohybrides présentent une excellente stabilité à l'oxydation tout en conservant la capacité catalytique dans la dégradation des polluants organiques après 30 jours.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP17382920.1 | 2017-12-28 | ||
EP17382920.1A EP3505627A1 (fr) | 2017-12-28 | 2017-12-28 | Matériau bionanohybride, son procédé de préparation et son utilisation |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2019129809A1 true WO2019129809A1 (fr) | 2019-07-04 |
Family
ID=61074273
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2018/097026 WO2019129809A1 (fr) | 2017-12-28 | 2018-12-27 | Matériau bionanohybride, son procédé de préparation et son utilisation |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP3505627A1 (fr) |
WO (1) | WO2019129809A1 (fr) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002093140A1 (fr) * | 2001-05-14 | 2002-11-21 | Johns Hopkins University | Nanocables magnetiques multifonctionnels |
WO2014132106A1 (fr) | 2013-02-27 | 2014-09-04 | University Of Calcutta | Préparation et utilisation de nanoparticules métalliques |
US8865116B2 (en) | 2012-03-20 | 2014-10-21 | Korea University Research And Business Foundation | Method for preparation of hematite iron oxide with different nanostructures and hematite iron oxide prepared thereby |
-
2017
- 2017-12-28 EP EP17382920.1A patent/EP3505627A1/fr not_active Withdrawn
-
2018
- 2018-12-27 WO PCT/EP2018/097026 patent/WO2019129809A1/fr active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002093140A1 (fr) * | 2001-05-14 | 2002-11-21 | Johns Hopkins University | Nanocables magnetiques multifonctionnels |
US8865116B2 (en) | 2012-03-20 | 2014-10-21 | Korea University Research And Business Foundation | Method for preparation of hematite iron oxide with different nanostructures and hematite iron oxide prepared thereby |
WO2014132106A1 (fr) | 2013-02-27 | 2014-09-04 | University Of Calcutta | Préparation et utilisation de nanoparticules métalliques |
Non-Patent Citations (18)
Title |
---|
ARAMI, H.; KHANDHAR, A.; LIGGITT, D.; KRISHNAN, K. M.: "In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles", CHEM. SOC. REV., vol. 44, 2015, pages 8576 |
BAUER, I.; KNOLKER, H.J.: "Iron Catalysis in Organic Synthesis", CHEM. REV., vol. 115, 2015, pages 3170 |
GAO, R.; ZHANG, H.; YAN, D.: "Iron diselenide nanoplatelets: Stable and efficient water-electrolysis catalysts", NANO ENERGY, vol. 31, 2017, pages 90 |
GEORGE K. LARSEN ET AL: "Multifunctional Fe 2 O 3 -Au Nanoparticles with Different Shapes: Enhanced Catalysis, Photothermal Effects, and Magnetic Recyclability", JOURNAL OF PHYSICAL CHEMISTRY C, vol. 120, no. 28, 21 July 2016 (2016-07-21), pages 15162 - 15172, XP055467305, ISSN: 1932-7447, DOI: 10.1021/acs.jpcc.6b03733 * |
GUO CHEN ET AL: "Direct binding glucoamylase onto carboxyl-functioned magnetic nanoparticles", BIOCHEMICAL ENGINEERING JOURNAL, ELSEVIER, AMSTERDAM, NL, vol. 67, 3 June 2012 (2012-06-03), pages 120 - 125, XP028408618, ISSN: 1369-703X, [retrieved on 20120609], DOI: 10.1016/J.BEJ.2012.06.002 * |
HUANG SHIH-HUNG ET AL: "Direct binding and characterization of lipase onto magnetic nanoparticles", BIOTECHNOLOGY PROGR, AMERICAN INSTITUTE OF CHEMICAL ENGINEERS, US, vol. 19, no. 3, 1 May 2003 (2003-05-01), pages 1095 - 1100, XP008096273, ISSN: 8756-7938, DOI: 10.1021/BP025587V * |
HUANG, Q.; CAO, M.; AI, Z.; ZHANG, L.: "Reactive oxygen species dependent degradation pathway of 4-chlorophenol with Fe@Fe C> core-shell nanowires", APPLIED CATALYSIS B: ENVIRON, vol. 162, 2015, pages 319, XP055466741, DOI: doi:10.1016/j.apcatb.2014.06.046 |
KIRK O ET AL: "Lipases from Candida antarctica: Unique Biocatalysts from a Unique Origin", ORGANIC PROCESS RESEARCH AND DEVELOPMENT, CAMBRIDGE, GB, vol. 6, no. 4, 27 June 2002 (2002-06-27), pages 446 - 451, XP002536951, DOI: 10.1021/OP0200165 * |
LUPAN, O.; POSTICA, V.; WOLFF, N.; POLONSKYI, O.; DUPPEL, V.; KAIDAS, V.; LAZARI, E.; ABABII, N.; FAUPEL, F.; KIENLE, L.: "Localized Synthesis of Iron Oxide Nanowires and Fabrication of High Performance Nanosensors Based on a Single Fe203 Nanowire", SMALL, 2017, pages 13 |
M. MISSON ET AL: "Nanobiocatalyst advancements and bioprocessing applications", JOURNAL OF THE ROYAL SOCIETY. INTERFACE, vol. 12, no. 102, 12 November 2014 (2014-11-12), GB, pages 20140891 - 20140891, XP055466734, ISSN: 1742-5689, DOI: 10.1098/rsif.2014.0891 * |
MARTINEZ-BANDERAS, A.I.; AIRES, A.; TERAN, F.J.; PEREZ, J.E.; CADENAS, J.F.; ALSHARIF, N.; RAVASI, T.; CORTAJARENA, A.L.; KOSEL, J: "Functionalized magnetic nanowires for chemical and magneto-mechanical induction of cancer cell death", SCIENTIFIC REPORTS, vol. 6, 2016 |
NOR, Y.A.; ZHOU, L.; MEKA, A.K.; XU, C.; NIU, Y.; ZHANG, H.; MITTER, N.; MAHONY, D.; YU, C.: "Engineering Iron Oxide Hollow Nanospheres to Enhance Antimicrobial Property: Understanding the Cytotoxic Origin in Organic Rich Environment", ADV. FUNC. MAT., vol. 26, 2016, pages 5408 |
POLSHETTIWAR, V.; ASEFA, T.: "Nanocatalysis: Synthesis and Applications", 2013, WILEY |
REDDY, L.H.; ARIAS, J.L.; NICOLAS, J.; COUVREUR, P.: "Magnetic nanoparticles: Design and characterization, toxicity and biocompatibility, pharmaceutical and biomedical applications", CHEM. REV., vol. 112, 2012, pages 5818 |
RUFUS, A.; SREEJU, N.; PHILIP, D.: "Synthesis of biogenic hematite (a-Fe203) nanoparticles for antibacterial and nanofluid applications", RSC ADVANCES, vol. 6, 2016, pages 94206 |
RUI, H.; WEI, L.; WEIWEI, P.; MINGGANG, Z.; DONG Z.; FA-SHEN L.: "1 D Magnetic Materials of Fe 0 and Fe with High Performance of Microwave Absorption Fabricated by Electrospinning Process", SCI. REP., vol. 4, 2014, pages 7493 |
SHYLESH, S.; SCHNEMANN, V.; THIEL, W. R., ANGEW. CHEM. INT. ED., vol. 49, 2010, pages 342 |
WANG, F.; WU, X.; SHEN, C.; WEN, Z.: "Facile synthesis of Fe@Fe C> core-shell nanowires as 0 electrode for high-energy Li-0 batteries", J. SOLID STATE ELECTROCHEM., vol. 20, 2016, pages 1831 |
Also Published As
Publication number | Publication date |
---|---|
EP3505627A1 (fr) | 2019-07-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Abd Elkodous et al. | Nanocomposite matrix conjugated with carbon nanomaterials for photocatalytic wastewater treatment | |
Abu-Dief et al. | Development and functionalization of magnetic nanoparticles as powerful and green catalysts for organic synthesis | |
Su | Environmental implications and applications of engineered nanoscale magnetite and its hybrid nanocomposites: A review of recent literature | |
Sargazi et al. | Ultrasound assisted reverse micelle efficient synthesis of new Ta-MOF@ Fe3O4 core/shell nanostructures as a novel candidate for lipase immobilization | |
Yang et al. | Synthesis and visible-light-driven photocatalytic activity of p–n heterojunction Ag2O/NaTaO3 nanocubes | |
Qin et al. | Template‐free fabrication of Bi2O3 and (BiO) 2CO3 nanotubes and their application in water treatment | |
Inbakandan et al. | Biosynthesis of gold nanoparticles utilizing marine sponge Acanthella elongata (Dendy, 1905) | |
Chi et al. | Fabrication of oxidase-like polyaniline-MnO2 hybrid nanowires and their sensitive colorimetric detection of sulfite and ascorbic acid | |
Mishra et al. | Facile synthesis of nano-structured magnetite in presence of natural surfactant for enhanced photocatalytic activity for water decomposition and Cr (VI) reduction | |
Sharma et al. | Facile fabrication of Zr2Ni1Cu7 trimetallic nano-alloy and its composite with Si3N4 for visible light assisted photodegradation of methylene blue | |
Nekouei et al. | Enhanced adsorption and catalytic oxidation of ciprofloxacin on hierarchical CuS hollow nanospheres@ N-doped cellulose nanocrystals hybrid composites: kinetic and radical generation mechanism studies | |
Zhang et al. | Synthesis of CdS hollow spheres coupled with g-C3N4 as efficient visible-light-driven photocatalysts | |
Jo et al. | Magnetically responsive SnFe2O4/g-C3N4 hybrid photocatalysts with remarkable visible-light-induced performance for degradation of environmentally hazardous substances and sustainable hydrogen production | |
Yang et al. | Magnetic single-enzyme nanoparticles with high activity and stability | |
Naghizadeh et al. | Novel CoFe2O4@ ZnO-CeO2 ternary nanocomposite: Sonochemical green synthesis using Crataegus microphylla extract, characterization and their application in catalytic and antibacterial activities | |
Wang et al. | Extract of Ginkgo biloba leaves mediated biosynthesis of catalytically active and recyclable silver nanoparticles | |
Shekofteh-Gohari et al. | Novel magnetically separable Fe3O4@ ZnO/AgCl nanocomposites with highly enhanced photocatalytic activities under visible-light irradiation | |
Hu et al. | In situ preparation of core-satellites nanostructural magnetic-Au NPs composite for catalytic degradation of organic contaminants | |
Wen et al. | Multifunctional magnetic branched polyethylenimine nanogels with in-situ generated Fe 3 O 4 and their applications as dye adsorbent and catalyst support | |
Balarabe et al. | Photocatalytic dye degradation by magnetic XFe2O3 (X: Co, Zn, Cr, Sr, Ni, Cu, Ba, Bi, and Mn) nanocomposites under visible light: A cost efficiency comparison | |
CN104399415B (zh) | 一种核壳式氧化石墨烯/银复合材料的制备方法 | |
Wang et al. | Preparation and characterization of multifunctional Fe3O4-coated Ag nanocomposites for catalytic reduction of 4-nitrophenol | |
Yang et al. | Self-assembly of bioinspired catecholic cyclodextrin TiO2 heterosupramolecule with high adsorption capacity and efficient visible-light photoactivity | |
Pei et al. | Biosynthesis of gold nanoparticles (AuNPs) by marine baitworm Marphysa moribidii idris, hutchings and arshad 2014 (annelida: polychaeta) and its antibacterial activity | |
Zhao et al. | Synthesis and characterization of a novel CNT-FeNi 3/DFNS/Cu (ii) magnetic nanocomposite for the photocatalytic degradation of tetracycline in wastewater |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 18830849 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 18830849 Country of ref document: EP Kind code of ref document: A1 |